ADALUZIS Trademark

Trademark Overview

On Tuesday, July 27, 2021, a trademark application was filed for ADALUZIS with the United States Patent and Trademark Office. The USPTO has given the ADALUZIS trademark a serial number of 90849710. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, December 16, 2024. This trademark is owned by Basilea Pharmaceutica AG. The ADALUZIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

General Information

Serial Number90849710
Word MarkADALUZIS
Filing DateTuesday, July 27, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBasilea Pharmaceutica AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Trademark Events

Event DateEvent Description
Friday, April 22, 2022NON-FINAL ACTION WRITTEN
Friday, July 30, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 22, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022NON-FINAL ACTION E-MAILED
Friday, April 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 1 FILED
Tuesday, June 27, 2023SOU EXTENSION 1 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 2 FILED
Tuesday, December 19, 2023SOU EXTENSION 2 GRANTED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU EXTENSION 3 GRANTED
Tuesday, July 2, 2024SOU EXTENSION 3 FILED
Monday, December 16, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2024SOU EXTENSION 4 GRANTED
Monday, December 16, 2024SOU EXTENSION 4 FILED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

adaluzis treatment diseases gastrointestinal neurological cardiovascular gynecological disorders dermatological preparations infectious